Yubo International Biotech Limited
YBGJ
$0.01
$0.01120.41%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 9.06% | -4.28% | 5.56% | -162.62% | 75.80% |
| Total Depreciation and Amortization | -96.56% | -34.46% | 1.83% | -3.33% | 1.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -415.15% | 127.27% | 71.36% | -335.57% | 38.80% |
| Change in Net Operating Assets | 518.52% | -73.60% | 371.74% | -163.11% | 113.68% |
| Cash from Operations | 59.41% | -60.87% | 64.13% | -2,465.00% | 96.43% |
| Capital Expenditure | -- | -- | -- | -- | 200.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -100.00% | 1,488.71% |
| Total Debt Issued | -64.01% | -42.89% | -- | -100.00% | -29.41% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -64.01% | -42.89% | -- | -100.00% | -29.41% |
| Foreign Exchange rate Adjustments | 270.00% | 97.06% | -147.22% | 234.38% | -317.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -30.43% | 179.31% | -680.00% | -16.67% | -78.57% |